Skip to main content
Livermore
Livermore
ZHEN

Riverbridge Partners LLC

SEC CIK
0001112325
Latest filing
Jul 13, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Riverbridge Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
232,514
Value
$83.5M
% of portfolio
2.3%
Quarters held
22
Since Q1 2021
Holdings of WST by Riverbridge Partners LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026232,514$83.5M2.3%−28,928−11.1%ReducedHolders
Q1 2026261,442$65.5M1.6%−57,171−17.9%ReducedHolders
Q4 2025318,613$87.7M1.6%−43,927−12.1%ReducedHolders
Q3 2025362,540$95.1M1.6%−20,980−5.5%ReducedHolders
Q2 2025383,520$83.9M1.4%−24,886−6.1%ReducedHolders
Q1 2025408,406$91.4M1.5%−26,887−6.2%ReducedHolders
Q4 2024435,293$142.6M1.9%−21,456−4.7%ReducedHolders
Q3 2024456,749$137.1M1.8%−30,187−6.2%ReducedHolders
Q2 2024486,936$160.4M2.2%−14,955−3.0%ReducedHolders
Q1 2024501,891$198.6M2.4%−14,132−2.7%ReducedHolders
Q4 2023516,023$181.7M2.3%−7,996−1.5%ReducedHolders
Q3 2023524,019$196.6M2.7%−39,484−7.0%ReducedHolders
Q2 2023563,503$215.5M2.7%+22,613+4.2%AddedHolders
Q1 2023540,890$187.4M2.6%+33,504+6.6%AddedHolders
Q4 2022507,386$119.4M1.8%−22,125−4.2%ReducedHolders
Q3 2022529,511$130.3M1.9%+65,985+14.2%AddedHolders
Q2 2022463,526$140.2M2.2%−92,868−16.7%ReducedHolders
Q1 2022556,394$228.5M2.6%−61,815−10.0%ReducedHolders
Q4 2021618,209$289.9M2.9%+240.0%AddedHolders
Q3 2021618,185$262.4M2.6%+1,433+0.2%AddedHolders
Q2 2021616,752$221.5M2.2%+24,628+4.2%AddedHolders
Q1 2021592,124$166.8M1.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.